Gamma interferon (IFN-y) activates the formation of a DNA-binding protein complex (FcRF'y) that recognizes the gamma response region (GRR) of the promoter for the human high-affinity Fcey receptor. In a membrane-enriched fraction prepared from human peripheral blood monocytes, IFN-y activation of FcRF-y occurred within 1 min and was ATP dependent. Activation of FcRF'y required a tyrosine kinase activity, and recognition of the GRR sequence by FcRF'y could be abrogated by treatment with a tyrosine-specific protein phosphatase. Treatment of cells with vanadate alone resulted in the formation of FcRF'y without the need for EFN--y. UV cross-linking and antibody competition experiments demonstrated that the FcRF'y complex was composed of at least two components: the 91-kDa protein of the IFN-oa-induced transcription complex ISGF3 and a 43-kDa component that bound directly to the GRR. Therefore, specificity for IFN-induced transcriptional activation of early response genes requires at least two events: (i) ligand-induced activation of membrane-associated protein by tyrosine phosphorylation and (ii) formation of a complex composed of an activated membrane protein(s) and a sequence-specific DNA-binding component.
The activation of macrophages and monocytes by gamma interferon (IFN--y) is critical for host defense against a variety of microorganisms (17) . One of the key responses induced by IFN--y is the induction of high-affinity receptors for the Fc portion of immunoglobulin G (Fc-yRI). These receptors are involved in phagocytosis, oxidative burst, and antibody-dependent-mediated cytotoxicity in phagocytic cells (for a review, see references 16, 21, and 26) . The gene for the FcyRI is transcriptionally activated within minutes by IFN--y in human monocytes such that steady-state levels of FcyRI mRNA increase within 30 min after exposure to IFN-y. Transfection studies have defined a gamma response region (GRR) within the promoter of the FcyRI gene that is responsible for IFN-y induction of the gene (19) . An IFN-,yactivated DNA-binding complex (FcRF-y) can be observed in the nuclear extracts of IFN-y-treated monocytes that specifically recognizes the GRR sequence (28) . Following exposure to IFN--y, FcRFy is formed within seconds, with maximal induction after 10 to 20 min.
We have recently developed an in vitro system in order to study transmembrane signaling of the IFN-a-activated transcription factor, interferon-stimulated gene factor 3 (ISGF3) (3) . Results from these studies suggest that both a tyrosine kinase and a tyrosine phosphatase activity are necessary for formation of ISGF3 (4) . Activation by IFN--y of the transcription factor GAF (gamma activating factor), which binds to the promoter of the guanylate binding protein gene (5) , also requires a tyrosine kinase and phosphatase (15) . We have now adopted this in vitro system with a membraneenriched fraction prepared from human peripheral blood monocytes in order to define in more detail the events governing the activation of FcRFy by IFN--y. * Corresponding author.
MATERIALS AND METHODS
Cells. Human monocytes were purified from leukopacks prepared by leukapheresis of normal volunteers by FicollHypaque sedimentation and then countercurrent centrifugal elutriation. Monocytes (>95% pure) were cultured in Dulbecco's modified Eagle medium (GIBCO, Grand Island, N.Y.) supplemented with 10% human AB serum (Sigma Chemical Co., St. Louis, Mo.) with 60 U of granulocyte macrophage colony-stimulating factor (GMCSF) per ml (20 x 107 U/mg) (kindly supplied by Schering Corp., Kenilworth, N.J.) for 4 to 6 days. After 4 days in culture with granulocyte macrophage colony-stimulating factor, monocytes express 7-to 10-fold more IFN--y receptors and increase in size, thereby making them more suitable for membrane preparations (6) .
Preparation of cell membranes. Monocytes were harvested by scraping into media and washed in phosphate-buffered saline. The cell pellet consisting of 2 x 108 to 3 x 108 cells was resuspended in a 1.5-fold volume of reaction buffer (100 mM NaF or NaCl; 20 mM MgCl2; 4 mM ATP; 200 F.M sodium ascorbate; 30 ,ug of pyruvate kinase per ml; 12 mM pyruvate; 100 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES; pH 7.9]; leupeptin, aprotinin, and pepstatin, each at 5 ,ug/ml; 600 ,uM phenylmethylsulfonyl fluoride) and lysed in a stainless steel Dounce homogenizer. The resulting cell lysate was centrifuged at 3,000 x g for 7 min at 4°C over a 38% sucrose cushion to sediment nuclei. The postnuclear lysate was then centrifuged for 10 min at 4°C at 13,000 x g in order to sediment cellular membranes. The membrane pellet was then washed (20 mM MgCl2, 100 mM HEPES, 200 ,uM ascorbate, and 600 ,uM phenylmethylsulfonyl fluoride) and resuspended in reaction buffer to which IFN--y was added at 200 ng/ml for 20 min at 30°C. The reaction was terminated by the addition of Nonidet P-40 or Triton X-100 to a final concentration of 0.1%. The ble-stranded oligonucleotide consisting of the GRR, 5'AGC ATGTTTCAAGGATTTGAGATGTATTTCCCAGAAA AG 3', as previously described (19, 28) . For those studies evaluating the role of ATP, membranes were resuspended in reaction buffer lacking ATP and pyruvate kinase. To this membrane preparation, IFN--y was added, and to a parallel tube, IFN-y plus ATP and pyruvate kinase was added.
Electrophoretic mobility shift assays (EMSA). The complex of FcRF-y and 32P-GRR were then separated on a 6% nondenaturing polyacrylamide gel as previously described (28 
RESULTS
In order to facilitate preparation of membranes, we utilized purified human peripheral blood monocytes that were cultured in granulocyte macrophage colony-stimulating factor for 4 to 6 days. These cells responded as well as fresh monocytes with regard to IFN-y induction of FcRF-y (5). Cells were homogenized, the homogenate was centrifuged over a 38% sucrose cushion, and the remaining membranes were sedimented from the nucleus-free supernatant, washed, and resuspended in reaction buffer. With lactate dehydrogenase as an enzymatic marker, these membrane preparations contained less than 5% contaminating cytosol and did not support the formation of ISGF3 by IFN-ax, which is dependent upon the cytosolic factor (ISGF3y) in order to form the complete complex (data not shown). IFN--y-induced formation of FcRF-y was then assayed by EMSA ( Fig.  1) with a whole-cell lysate (lanes 1 and 2), the supernatant fraction (lanes 3 and 4), and the membrane fraction (lanes 5 and 6). IFN--y induced the formation of FcRF-y both in the whole-cell homogenate and in the membrane-enriched fraction but not in the membrane-depleted supernatant fraction. Therefore, in contrast to the activation of ISGF3 by IFN-a, all the components necessary for IFN--y induction of FcRF-y were retained in the membrane-enriched fraction. Prior incubation of membranes with a monoclonal antibody (-yR38) (8) against the IFN-y receptor abrogated formation of FcRF-y ( Fig. 1 , lanes 7 to 9), confirming that activation of FcRF-y required the IFN--y receptor.
Activation of the FcRF-y complex occurred within minutes following IFN-y binding to intact monocytes (28) , and the kinetics of IFN-y-induced FcRF-y on isolated membranes paralleled that seen in intact cells (Fig. 2) . On membranes, FcRFy could be observed within 60 s after exposure to IFN--y (lanes 1 vs 2), and maximal induction occurred within 15 min (lane 6). FcRF-y bound to the GRR specifically such that only an oligonucleotide consisting of the GRR of the FcyRI promoter inhibited FcRFy formation (Fig. 2, lane 11) . There was no inhibition by the gamma activating sequence from the IFN-y-induced gene, guanylate-binding protein (Fig. 2, lane 10 ). An oligonucleotide containing the IFNstimulated response element (ISRE) from the ISG54 gene inhibited binding of the constitutive band but had no effect on FcRFy (Fig. 2, lane 9) . These findings were similar to those observed with nuclear extracts prepared from IFN--ytreated monocytes assayed for FcRFy binding to the GRR (28) . Since in vitro formation of ISGF3 by IFN-a and GAF by IFN-y required ATP (3, 14) , similar studies were performed with respect to FcRF-y activation by IFN-y. There was marked attenuation of FcRFy formation when membranes were prepared in the absence of exogenous ATP and incubated with IFN-y (Fig. 3a, lane 3) . The addition of ATP restored the ability of IFN--y to activate FcRF-y (Fig. 3a, lane 2). If adenylyl (3,By-methylene)-diphosphonate (AMP-PCP), a nonhydrolyzable ATP analog, was added instead of ATP, the generation of FcRF-y was also completely abrogated (Fig. 3a, lane 4) . These findings suggested that a phosphorylation reaction was required for the IFN-y-induced activation of this protein-DNA complex. In order to better define the class of kinase necessary for the activation of FcRFy, we measured the effect of two protein kinase inhibitors on IFN--y-induced formation of FcRFy in our cell-free system. At concentrations (500 nM) that inhibit most serine, threonine and tyrosine kinase reactions, staurosporin inhibited IFN--y-induced FcRF-yl and 2 (Fig. 3b, lanes 1 to 3) . Lower concentrations of staurosporin (10 nM) which are known to specifically inhibit protein kinase C were ineffective (data not shown). Genistein, a specific tyrosine kinase inhibitor, prevented the formation of FcRF-yl but was without effect on the formation of FcRFy2 (Fig. 3b, lanes 4 to 6) . Both of these findings were consistent with experiments using intact cells. Staurosporin at 500 nM virtually completely prevented the activation of FcRFy1 and FcRF-y2, whereas genistein only partially inhibited the formation of FcRF-y (27 and unpublished observations). These findings suggested that activation of FcRFyl and -2 required a kinase activity that was at least in part tyrosine kinase mediated. However, the involvement of other classes of kinases could not be ruled out. To determine if phosphorylated tyrosines in the proteins of the activated FcRF-y complex were necessary for recognition of the GRR element, we treated GRR affinity-purified FcRF-y with a recombinant protein tyrosine phosphatase from Yersinia enterocolitica (12) . Treatment of purified FcRF-y with this tyrosine phosphatase destroyed the ability of the complex to recognize the GRR (Fig. 3c, lanes 1 and 2) . Addition of vanadate (a tyrosine phosphatase inhibitor) markedly diminished the effect (Fig. 3c, lane 3) .
Recent studies have indicated that formation of GAF by IFN--y required a ligand-activated tyrosine kinase and phosphatase activity (15 lent to that of IFN-y (Fig. 4a, lanes 1 to 3) . Vanadate treatment of monocyte membranes also resulted in the activation of the transcription complex, ISGF3, which recognizes the IFN-a-stimulated response element, ISRE (data not shown). In addition, exposure of intact monocytes to the combination of vanadate and H202 resulted in activation of FcRFy (Fig. 4a, lanes 4 to 6) . We next examined whether there was an increase in specific cellular gene mRNA in monocytes that were treated with the combination of vanadate and H202. Although there was no enhancement of steady-state levels of RNA for the Fc-yRI gene in response to the combined treatment (data not shown), there were increased concentrations of GBP and ISG54 RNAs (Fig. 4b) , both of which contain an ISRE in their promoter region. Although vanadate is generally known to inhibit protein tyrosine phosphatases (9) , it may also directly stimulate protein tyrosine kinases such that some insulin-regulated signaling events can be mimicked by this agent (13, 14, 25) . It therefore remains unclear whether vanadate activates FcRF-y and induces ISG54 and GBP mRNA by decreasing FIG. 5. The FcRFy complex contains the 91-kDa protein (ISGF3, 91 kDa) and a 43-kDa protein which interacts directly with the GRR. (a) Anti-91-kDa protein antibodies were prepared as described in the text. These antibodies in the form of antisera or control rabbit serum (CTRL SERUM) were incubated with FcRF-y generated either from nuclear extracts (NUCL. EXT.; lanes 1 and 2) or isolated membranes (MB; lanes 3 and 4) for 1 h at 4°C. The resulting material was then assayed by EMSA. (b) Nuclear extract containing FcRF-y was separated by EMSA (lane 1). The entire gel was then UV cross-linked for 20 min in a Stratagene. Stratalinker. A 1-h exposed autoradiograph of the gel was obtained, and the area of the gel corresponding to the shifted FcRFy1 and FcRF-y2 was excised, equilibrated in SDS sample buffer, and placed into the wells of an SDS-polyacrylamide gel (lanes 2 and 3) . During the electrophoretic elution of the cross-linked sample from the EMSA gel into the SDS gel, the cross-linked product tends to migrate along the margin of the lanes. the activity of constitutively active tyrosine phosphatases or by enhancing the activity of a tyrosine kinase. Alternatively, an indirect effect of vanadate cannot be absolutely excluded. Nevertheless, this is the first example of any agent that can induce a response which specifically requires the binding of IFN-y or IFN-ax to their respective receptors.
It has recently been established that ISGF3a consists of three proteins (molecular masses of 113, 91, and 84 kDa) that are tyrosine phosphorylated in response to . To form the complete complex, these three proteins interact with ISGF3y (48 kDa), which is necessary for binding to the ISRE. The 91-kDa protein is also phosphorylated in response to IFN--y (23, 24) . In order to determine if the 91-kDa protein is a component of FcRFy, we prepared antibodies directed against the 39 carboxy-terminal amino acids of the 91-kDa protein (22) . Incubation of FcRF-y generated from either IFN-y-activated nuclear extracts prepared from intact cells (Fig. 5a, lanes 1 and 2) or from membranes (Fig. 5a , lanes 3 and 4) with these antibodies prior to addition of 32P-GRR induced a "supershift" of both FcRF-yl and FcRF-y2. The supershift could be abrogated by the addition of antigenic peptide (data not shown). These data provide evidence that the 91-kDa protein is a component of both shifted complexes and support a potential mechanism by which certain genes can be induced by both IFN-a and IFN--y. To determine if the FcRF-y complex consisted of another component that specifically recognized the GRR element in a manner similar to ISGF3-y for the ISRE sequence, we UV cross-linked both FcRF-yl and FcRF-y2 after separation by EMSA (Fig. Sb, lane 1) . The cross-linked VOL. 13, 1993 at UNIV OF CALIF SAN DIEGO on August 2, 2007 mcb.asm.org Downloaded from products were then resolved by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) analysis. Both FcRFy1 and FcRF-y2 complexes revealed a 57-kDa DNA-protein complex, the protein portion of which was estimated to have a molecular mass of 43 kDa (Fig. 3b, lane  2 and 3) . No 57-kDa complex was present in the absence of UV cross-linking (data not shown). Since only the shifted FcRFy complex was analyzed by SDS-PAGE and this complex was completely inhibited by excess GRR (28) (Fig.   2) , the 57-kDa cross-linked product is specific for FcRFy.
DISCUSSION
The requirement for ATP, inhibition only with high concentrations of staurosporin, partial inhibition by genistein, the presence of the 91-kDa protein (a known tyrosinephosphorylated protein) in the complex, the activation of FcRF-y by vanadate alone, and the sensitivity of FcRFy to protein tyrosine phosphatase treatment-all indicate the need for a ligand-induced tyrosine kinase activity for FcRFy activation by IFN--y. The finding that genistein only partially inhibited the formation of FcRF-y probably reflects the selective nature of genistein's action on tyrosine kinases. For instance, genistein had essentially no effect on T-cell signalling, which is well characterized as mediated by receptor-associated tyrosine kinases (10) . The ability of vanadate alone to cause the formation of FcRF-y, both in vitro and in vivo, is the first example of an agent that can initiate a specific IFN--y-induced signal by bypassing the receptor. This agent not only activates transcription factors (FcRF-y and ISGF3) but also is sufficient to increase the corresponding cellular RNAs for the ISG54 and GBP genes. The inability of vanadate to induce Fc-yRI RNA may be due to the requirement for other tissue-specific factors which do not interact with the GRR in order to initiate transcription (19) , whereas IFN-a-activated gene expression requires only binding to the ISRE. This is also supported by the observation that vanadate also induced expression of GBP RNA, a gene that requires only an overlapping ISRE and gamma activating sequence element in its promoter for IFN inducibility (5) . It remains to be determined whether vanadate induces FcRF-y formation by directly activating a tyrosine kinase or by inhibiting a constitutively active tyrosine phosphatase(s). Since vanadate also induces the formation of ISGF3 in monocyte membranes and not in HeLa cells (where it actually inhibits IFN-a-induced ISGF3 formation), monocytes like T cells (7, 18) or neutrophils (11) may have a high level of constitutively active tyrosine phosphatases. By inhibiting these phosphatases, vanadate may allow for the simultaneous activation of a kinase necessary for the induction of FcRF-y and a decrease in phosphatase-induced degradation of FcRF-y.
In contrast to the formation of the complete IFN-ainduced complex (ISGF3), which requires both membraneassociated proteins (ISGF3ac) and a cytosolic DNA-binding component (ISGF3-y) (3), the activation of the FcRF-y complex takes place entirely on a membrane fraction. This finding suggests that all the components necessary for IFN-y to initiate a transmembrane signal must be localized to the membrane fraction. This would include, in addition to the 90-kDa receptor that binds IFN--y, a tyrosine kinase, the FcRFy transcription factors (i.e., the 91-and 43-kDa proteins), and possibly a tyrosine phosphatase. Although a tyrosine protein kinase (tyk2) has been recently implicated in the signal transduction pathway for IFN-a (27) , no related (jakl orjak2 family) or unrelated tyrosine kinase (src family) has been specifically identified with the IFN-y signalling cascade. Of interest is the finding that jakl mRNA (29) and the src-like kinase, hck (1), can be specifically upregulated in monocytes by treatment with IFN-y. However, no data as yet link either kinase to the immediate events surrounding IFN-,y signal transduction.
The FcRF-y complex consists of at least two protein components: (i) the 91-kDa protein, a tyrosine-phosphorylated protein that is part of the ISGF3ao complex, and (ii) a 43-kDa protein that binds specifically to the GRR. Although it is not known whether the 43-kDa component is modified by the binding of IFN-y to its receptor, this protein is clearly different from ISGF3-y, its counterpart in the ISGF3 complex. Whereas the ISGF3-y component is N-ethylmaleimide sensitive (with respect to DNA binding) (19) , the 43-kDa component is not (data not shown), nor does the ISRE competitively inhibit the binding of FcRFy to the GRR (27) . In addition, ISGF3-y is constitutively expressed in the cytoplasm and nucleus, and the 43-kDa GRR-binding component is clearly part of the membrane fraction. The 91-kDa protein is also a part of the IFN-y-activated transcription factor, GAF (22) . It is conceivable that proteins such as the 91-kDa protein are tyrosine phosphorylated in response to either IFN--y or IFN-ao and then act as cofactors to enhance the affinity of specific sets of DNA-binding proteins for their promoter elements. The specificity of gene activation for a given cytokine may, therefore, require both a combination of cofactor proteins activated by tyrosine phosphorylation upon ligand binding and the availability of specific sets of DNA-binding proteins, the latter of which may either be tissue specific or sequestered within particular subcellular compartments.
